FC(F)(F)S([O:6][S:7]([C:10]([F:13])([F:12])[F:11])(=[O:9])=[O:8])(=O)=O.N1C=CC=C[CH:17]=1.C(O[C:30]1[CH:39]=[C:38]2[C:33]([C:34](=[S:40])[NH:35][CH:36]=[N:37]2)=[CH:32][CH:31]=1)C1C=CC=CC=1.Cl>C(Cl)Cl>[CH3:17][S:40][C:34]1[C:33]2[C:38](=[CH:39][C:30]([O:6][S:7]([C:10]([F:11])([F:12])[F:13])(=[O:8])=[O:9])=[CH:31][CH:32]=2)[N:37]=[CH:36][N:35]=1Trifluoromethane sulfonic anhydride (0.96 ml, 5.73 mmol) and pyridine (0.46 ml, 5.73 mmol) were added to a solution of 7-benzyloxy-3,4-dihydroquinazolin-4-thione (1.0 g, 5.21 mmol) in methylene chloride (20 ml) at 0° C. for 1.5 hour. Hydrochloric acid (0.5 N) was then added to the mixture which was extracted with ethyl acetate. The organic phase was washed brine, dried over magnesium sulphate and the solvents were removed in vacuo. Purification by flash chromatography on silica gel, eluting with isohexane/ethyl acetate (1:4) yielded 4-(methylthio)-7-(trifluoromethanesulphonyloxy)quinazoline (800 mg, 50% yield):
読み込み中…
